FDA Inspection
NerPharMa S.r.l.NerPharMa S.r.l. – FDA Inspection, Feb 20, 2023
Record Details
This FDA Inspection record concerns NerPharMa S.r.l., with an inspection on February 20, 2023, issued by the Office of Inspections and Investigations.
- Company
- NerPharMa S.r.l.
- Inspection Date
- February 20, 2023
View Company Profile
ID · 8b7b8a06-c064-40dc-ae66-cc7fb620ca39
Inspection Facts
- Inspection number
- 1199864
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of NerPharMa S.r.l.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2025 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| September 13, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2024 | Not classified | Office of Inspections and Investigations | |
| January 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for NerPharMa S.r.l.
- FDA Inspection 1273996 - 2025-06-27
- FDA Inspection 1271174 - 2024-09-13
- FDA Inspection 1243307 - 2024-06-19
- FDA Inspection 1142104 - 2020-01-17
- FDA Inspection 1072258 - 2018-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.